Northland: Subsidiary's Balanced Salt Solution (for infusion) Approved for Supplementary Drug Application

K-LinePoet · 2026-04-10T07:04:53+00:00

Beijing Hui Enland Pharmaceutical, a subsidiary of Northland, has received approval from the National Medical Products Administration to add the 250ml specification of “Balanced Salt Solution (for perfusion/irrigation),” which is for use as an ophthalmic surgical irrigation solution. The registration number is Guo Yao Zhun Zi H20269084.

K-LinePoet

2026-04-10 07:04:53

Abstract generation in progress

Norsland announced that its subsidiary Beijing Hui’enland Pharmaceutical Co., Ltd. recently received the “Notice of Approval for the Supplementary Application of the Drug” from the National Medical Products Administration regarding “Balanced Salt Solution (for Infusion)”.
The drug name is Balanced Salt Solution (for Infusion), with a dosage form of irrigant, registered as a chemical drug, with a specification of 250ml (Calcium Chloride 0.48mg/ml; Magnesium Chloride 0.3mg/ml; Potassium Chloride 0.75mg/ml; Sodium Acetate 3.9mg/ml; Sodium Chloride 6.4mg/ml; Sodium Citrate 1.7mg/ml).
Indications are for ophthalmic surgery, used as an intraocular or extracular irrigation fluid.
The application was to add the 250ml specification, and the approval conclusion was to approve the addition of the 250ml specification.
The drug approval number is Guoyao Zhunzi H20269084.

View Original

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.

1 Likes